Sandra Tourt-Uhlig

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Jeremy N. Rich, David A. Reardon, Terry Peery et al. · Journal of Clinical Oncology · 2003 · 736 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I Trial of Temozolomide Plus <i>O</i>⁶-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma

Jennifer A. Quinn, Annick Desjardins, Jon Weingart et al. · Journal of Clinical Oncology · 2005 · 292 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma

Jennifer A. Quinn, David A. Reardon, Allan H. Friedman et al. · Journal of Clinical Oncology · 2003 · 257 citations

Medicine, Pharmacology, Pharmacotherapy +16

Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

John H. Sampson, Gamal Akabani, Gary E. Archer et al. · Journal of Neuro-Oncology · 2003 · 239 citations

Medicine, Neuroscience, Oncology +8

Phase II Trial of Carmustine Plus O⁶-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma

Jennifer A. Quinn, James M. Pluda, M. Eileen Dolan et al. · Journal of Clinical Oncology · 2002 · 194 citations

Medicine, Oncology, Pharmacology +17